Loading...

We've got a brand new version of Simply Wall St! Try it out

CB2 Insights

CNSX:CBII
Snowflake Description

Overvalued with weak fundamentals.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
CBII
CNSX
CA$12M
Market Cap
  1. Home
  2. CA
  3. Healthcare
Company description

CB2 Insights Inc. provides predictive analytics tools, data-driven software, and comprehensive services for the cannabis value chain industry the United States, Canada, and internationally. The last earnings update was 18 days ago. More info.


Add to Portfolio Compare Print
  • CB2 Insights has significant price volatility in the past 3 months.
CBII Share Price and Events
7 Day Returns
0%
CNSX:CBII
6.1%
CA Healthcare Services
1.2%
CA Market
1 Year Returns
-
CNSX:CBII
-53.6%
CA Healthcare Services
-0.2%
CA Market
CBII Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
CB2 Insights (CBII) 0% -12.1% -14.7% - - -
CA Healthcare Services 6.1% 11% 2.1% -53.6% -21.7% 45.5%
CA Market 1.2% 4.2% 1.5% -0.2% 8.4% 1.8%
1 Year Return vs Industry and Market
  • No trading data on CBII.
  • No trading data on CBII.
Price Volatility
Industry
5yr Volatility vs Market

Value

 Is CB2 Insights undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for CB2 Insights. This is due to cash flow or dividend data being unavailable. The share price is CA$0.145.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for CB2 Insights's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are CB2 Insights's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
CNSX:CBII PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-06-30) in CAD CA$-0.11
CNSX:CBII Share Price ** CNSX (2019-09-13) in CAD CA$0.15
North America Healthcare Services Industry PE Ratio Median Figure of 13 Publicly-Listed Healthcare Services Companies 62.4x
Canada Market PE Ratio Median Figure of 538 Publicly-Listed Companies 14.15x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of CB2 Insights.

CNSX:CBII PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= CNSX:CBII Share Price ÷ EPS (both in CAD)

= 0.15 ÷ -0.11

-1.3x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • CB2 Insights is loss making, we can't compare its value to the North America Healthcare Services industry average.
  • CB2 Insights is loss making, we can't compare the value of its earnings to the Canada market.
Price based on expected Growth
Does CB2 Insights's expected growth come at a high price?
Raw Data
CNSX:CBII PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -1.3x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
North America Healthcare Services Industry PEG Ratio Median Figure of 11 Publicly-Listed Healthcare Services Companies 2.43x
Canada Market PEG Ratio Median Figure of 246 Publicly-Listed Companies 0.98x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for CB2 Insights, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on CB2 Insights's assets?
Raw Data
CNSX:CBII PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-06-30) in CAD CA$0.08
CNSX:CBII Share Price * CNSX (2019-09-13) in CAD CA$0.15
Canada Healthcare Services Industry PB Ratio Median Figure of 11 Publicly-Listed Healthcare Services Companies 1.77x
Canada Market PB Ratio Median Figure of 2,452 Publicly-Listed Companies 1.44x
CNSX:CBII PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= CNSX:CBII Share Price ÷ Book Value per Share (both in CAD)

= 0.15 ÷ 0.08

1.77x

* Primary Listing of CB2 Insights.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • CB2 Insights is good value based on assets compared to the CA Healthcare Services industry average.
X
Value checks
We assess CB2 Insights's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare Services industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare Services industry average (and greater than 0)? (1 check)
  5. CB2 Insights has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is CB2 Insights expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as CB2 Insights has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
28%
Expected Healthcare Services industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is CB2 Insights expected to grow at an attractive rate?
  • Unable to compare CB2 Insights's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare CB2 Insights's earnings growth to the Canada market average as no estimate data is available.
  • Unable to compare CB2 Insights's revenue growth to the Canada market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
CNSX:CBII Future Growth Rates Data Sources
Data Point Source Value (per year)
North America Healthcare Services Industry Earnings Growth Rate Market Cap Weighted Average 28%
North America Healthcare Services Industry Revenue Growth Rate Market Cap Weighted Average 13%
Canada Market Earnings Growth Rate Market Cap Weighted Average 12.6%
Canada Market Revenue Growth Rate Market Cap Weighted Average 6%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
CNSX:CBII Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in CAD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
CNSX:CBII Past Financials Data
Date (Data in CAD Millions) Revenue Cash Flow Net Income *
2019-06-30 11 -3 -7
2019-03-31 11 -2 -6
2018-12-31 11 -1 -4
2018-09-30 9 -1 -2
2017-12-31 0 -1 -1
2016-12-31 0 0 0

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if CB2 Insights is high growth as no earnings estimate data is available.
  • Unable to determine if CB2 Insights is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
CNSX:CBII Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (2 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from CB2 Insights Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:CBII Past Financials Data
Date (Data in CAD Millions) EPS *
2019-06-30 -0.11
2019-03-31 -0.10
2018-12-31 -0.07
2018-09-30 -0.04
2017-12-31 -0.03
2016-12-31 -0.01

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if CB2 Insights will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. CB2 Insights's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Healthcare companies here
  2. CB2 Insights's competitive advantages and company strategy can generally be found in its financial reports archived here.
  3. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess CB2 Insights's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the North America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the North America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
CB2 Insights has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has CB2 Insights performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare CB2 Insights's growth in the last year to its industry (Healthcare Services).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • CB2 Insights does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare CB2 Insights's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare CB2 Insights's 1-year growth to the North America Healthcare Services industry average as it is not currently profitable.
Earnings and Revenue History
CB2 Insights's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from CB2 Insights Company Filings, last reported 2 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

CNSX:CBII Past Revenue, Cash Flow and Net Income Data
Date (Data in CAD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-06-30 11.43 -7.47 12.43
2019-03-31 10.97 -5.76 10.89
2018-12-31 10.77 -3.66 9.77
2018-09-30 8.56 -2.27 9.44
2017-12-31 0.28 -1.26 1.22
2016-12-31 0.00 -0.15 0.15
2015-12-31 -0.10 0.10

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if CB2 Insights has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if CB2 Insights has efficiently used its assets last year compared to the North America Healthcare Services industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if CB2 Insights improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess CB2 Insights's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare Services industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
CB2 Insights has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is CB2 Insights's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up CB2 Insights's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • CB2 Insights's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
  • CB2 Insights's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of CB2 Insights's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.4x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from CB2 Insights Company Filings, last reported 2 months ago.

CNSX:CBII Past Debt and Equity Data
Date (Data in CAD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-06-30 6.46 4.06 1.28
2019-03-31 7.92 3.27 1.59
2018-12-31 5.85 4.26 0.43
2018-09-30 7.39 4.15 3.02
2017-12-31 4.98 4.05 1.01
2016-12-31 0.18 0.01 0.04
2015-12-31
  • CB2 Insights's level of debt (62.9%) compared to net worth is high (greater than 40%).
  • Unable to establish if CB2 Insights's debt level has increased without past 5-year debt data.
CASH RUNWAY ANALYSIS

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

  • CB2 Insights has less than a year of cash runway based on current free cash flow.
  • CB2 Insights has less than a year of cash runway if free cash flow continues to grow at historical rates of 69.8% each year.
X
Financial health checks
We assess CB2 Insights's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. CB2 Insights has a total score of 0/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is CB2 Insights's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from CB2 Insights dividends.
If you bought CA$2,000 of CB2 Insights shares you are expected to receive CA$0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate CB2 Insights's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate CB2 Insights's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
CNSX:CBII Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Global Healthcare Services Industry Average Dividend Yield Market Cap Weighted Average of 23 Stocks 1%
Canada Market Average Dividend Yield Market Cap Weighted Average of 333 Stocks 3.5%
Canada Minimum Threshold Dividend Yield 10th Percentile 1.2%
Canada Bottom 25% Dividend Yield 25th Percentile 2%
Canada Top 25% Dividend Yield 75th Percentile 5.8%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as CB2 Insights has not reported any payouts.
  • Unable to verify if CB2 Insights's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of CB2 Insights's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as CB2 Insights has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess CB2 Insights's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can CB2 Insights afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. CB2 Insights has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of CB2 Insights's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Prad Sekar
CEO Bio

Mr. Pradyum Sekar, also known as Prad, serves as Chief Executive Officer, Co-Founder and Secretary at CB2 Insights Inc. and serves as its Executive Director since February 27, 2019.

CEO Compensation
  • Insufficient data for Prad to compare compensation growth.
  • Insufficient data for Prad to establish whether their remuneration is reasonable compared to companies of similar size in Canada.
Management Team Tenure

Average tenure of the CB2 Insights management team in years:

0.6
Average Tenure
  • The average tenure for the CB2 Insights management team is less than 2 years, this suggests a new team.
Management Team

Prad Sekar

TITLE
CEO, Co-Founder

Kash Qureshi

TITLE
President

Carm Marrelli

TITLE
Chief Financial Officer
AGE
48
TENURE
0.6 yrs

Dan Thompson

TITLE
Chief Corporate Officer
TENURE
0.1 yrs

Kishan Mahabir

TITLE
Chief Medical Officer
TENURE
0.7 yrs
Board of Directors Tenure

Average tenure of the CB2 Insights board of directors in years:

0.4
Average Tenure
  • The average tenure for the CB2 Insights board of directors is less than 3 years, this suggests a new board.
Board of Directors

David Danziger

TITLE
Chairman of the Board
AGE
62
TENURE
0.3 yrs

Prad Sekar

TITLE
CEO, Co-Founder
TENURE
0.6 yrs

Kash Qureshi

TITLE
President
TENURE
0.6 yrs

Gerry Goldberg

TITLE
Director
AGE
75
TENURE
0.1 yrs

Norton Singhavon

TITLE
Director
TENURE
0.6 yrs

Marc Adelson

TITLE
Director
TENURE
0.4 yrs

Peter Cummins

TITLE
Director
TENURE
0.2 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CA$) Value (CA$)
03. Jun 19 Buy Norton Singhavon Individual 19. Mar 19 19. Mar 19 10,000 CA$0.33 CA$3,300
X
Management checks
We assess CB2 Insights's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. CB2 Insights has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Is CB2 Insights (CNSX:CBII) Weighed On By Its Debt Load?

What we care about is avoiding the permanent loss of capital.' So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too much debt can sink a company. … When we think about a company's use of debt, we first look at cash and debt together. … CNSX:CBII Historical Debt, July 30th 2019 How Strong Is CB2 Insights's Balance Sheet?

Simply Wall St -

Company Info

Description

CB2 Insights Inc. provides predictive analytics tools, data-driven software, and comprehensive services for the cannabis value chain industry the United States, Canada, and internationally. The company develops an integrated cloud-based productivity and business intelligence software platform for the cannabis industry. It offers cannabis-focused electronic medical record platform with a suite of practice management tools to support the workflows of a clinician and/or their clinical practice in medical cannabis under the Sail Cannabis brand. The company also provides comprehensive services to patients looking to integrate cannabis into their treatment regimen through cannabis evaluation and education centers; support services to clinicians for a fully-managed business model to assist in their medical cannabis practice; and telemedicine applications. It operates a network of 28 cannabis evaluation centers under the Canna Care Docs brand name in 12 states of the United States. In addition, the company provides TokeIn, a consumer loyalty and engagement application that works with dispensaries and other retailers in the cannabis space to understand the purchasing patterns. It markets its products to cultivators of cannabis, distribution intermediaries, retail channels, and cannabis clinics and clinicians, as well as specialty clinics, such as pain and oncology clinics through channel and direct strategies. CB2 Insights Inc. was founded in 2014 and is headquartered in Mississauga, Canada.

Details
Name: CB2 Insights Inc.
CBII
Exchange: CNSX
Founded: 2014
CA$12,147,802
83,777,948
Website: http://cb2insights.com
Address: CB2 Insights Inc.
5045 Orbitor Drive,
Building 11,
Mississauga,
Ontario, L4W 4Y4,
Canada
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
CNSX CBII Class A Common Shares Canadian National Stock Exchange CA CAD 06. Mar 2019
OTCPK CBII.F Class A Common Shares Pink Sheets LLC US USD 06. Mar 2019
Number of employees
Current staff
Staff numbers
0
CB2 Insights employees.
Industry
Health Care Technology
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/09/15 01:41
End of day share price update: 2019/09/13 00:00
Last earnings filing: 2019/08/28
Last earnings reported: 2019/06/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.